MIB joins the France Biotech network
Marseille, 9 october 2026 – Aix-Marseille Université, the coordinating institution of the Marseille Immunology Biocluster (MIB) consortium, has joined France Biotech. This membership will enable MIB to take part in national discussions on the development of healthcare innovation companies and strengthen its ties with organisations across the sector.
France Biotech is an independent association bringing together healthcare entrepreneurs and their expert partners in France. Its network provides a forum for collaboration and discussion on the challenges facing companies in the health technology sector, also known as HealthTech.
Contributing to discussions on business development
This membership will enable MIB teams to contribute to the network’s work on topics such as financing, clinical development and industrialisation. It will also provide opportunities to exchange insights with biotech companies, investors and business support organisations on companies’ needs at different stages of development.
Better connecting the biocluster’s resources with companies’ needs
For MIB, this participation complements its work with companies in immunology and organisations within its ecosystem. Exchanges within France Biotech are intended to help better connect the biocluster’s scientific and clinical resources with companies’ needs.
Partager
Actualités